Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/13/25 20:00 | 3/12/25 | SRPT | Health | Drug | Pharmaceutical Preparations | Nicaise Claude | MA | D | 2 | M.d | 494 | 40.34 | 0 | 12 | 79 | 28 | D | |||||||||||||||
3/13/25 20:00 | 3/12/25 | SRPT | Health | Drug | Pharmaceutical Preparations | Nicaise Claude | MA | D | 2 | S.d | -494 | 40.34 | 0 | -12 | 28 | D | ||||||||||||||||
3/11/25 20:00 | 3/7/25 | SRPT | Health | Drug | Pharmaceutical Preparations | Estepan Ian Michael | MA | O | CFO | 3 | M.d | 190 | 4.89 | 0 | 39 | 163 | 63 | D | ||||||||||||||
3/11/25 20:00 | 3/7/25 | SRPT | Health | Drug | Pharmaceutical Preparations | Rodino-Klapac Louise | MA | O | Head of | 2 | M.d | 0 | 0.00 | 0 | 23 | 37 | 85 | D | ||||||||||||||
3/11/25 20:00 | 3/7/25 | SRPT | Health | Drug | Pharmaceutical Preparations | Murray Dallan | MA | O | Chief Cu | 2 | M.d | 0 | 0.00 | 0 | 23 | 151 | 38 | D | ||||||||||||||
3/10/25 20:00 | 3/6/25 | SRPT | Health | Drug | Pharmaceutical Preparations | Arif Bilal | MA | O | Chief Te | 1 | M.d | 0 | 0.00 | 0 | 18 | 241 | 25 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |